- 期刊
腹膜透析患者對COVID-19傳染的應變與對策
Adaptions and Strategies to COVID-19 Pandemic Environment for Peritoneal Dialysis Patient
摘要
自從2019年底開始，全球開始因嚴重特殊傳染性肺炎新型冠狀病毒（severe acute respiratory syndrome coronavirus 2, SARS-CoV-2）感染造成嚴重感染病死亡。然而，對於末期腎病變患者，因常合併較多共病且年紀較大，這些患者特別容易受到新冠肺炎（coronavirus disease 2019, COVID-19）的危害。因這群患者須長期接受血液透析或腹膜透析（peritoneal dialysis, PD），頻繁出入醫療院所，較容易受到COVID-19感染風險。PD患者雖然大多以居家為主，但仍有相對高的感染風險。以下將針PD患者討論關於COVID-19感染的應變以及對策。
並列摘要
At the end of 2019, the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has significantly increased mortality to whole world. However, patients with end-stage renal disease are particularly vulnerable when infected with COVID-19 because they have multiple comorbidities and are older. These patients are higher risk of COVID-19 infection because they often enter to medical institutions for hemodialysis or peritoneal dialysis (PD). Although PD patients are always at home, they still have a relatively high risk of infection. The article will discuss the response and countermeasures of COVID-19 for peritoneal dialysis patients.
延伸閱讀
- 許高鳴、邱炳芳（2021）。慢性血液透析患者對COVID-19傳染的應變與對策。腎臟與透析，33(3)，120-125。https://doi.org/10.6340/KD.202109_33(3).0003
- 廖秋萍、闕淑能、劉蕙婷、陳怡婷、楊紹佑、姜至剛、林水龍、洪冠予、陳永銘（2022）。腹膜透析患者接種SARS-CoV-2疫苗現況分析－北區醫學中心經驗。腎臟與透析，34(4)，199-204。https://doi.org/10.6340/KD.202212_34(4).0009
- Chen, C. S., Chung, S. Y., Lai, M. N., Chou, M. Y., Cheng, Y. W., Hsu, I. S., & Kao, M. T. (2000). 腹膜透析併發格蘭氏陰性菌腹膜炎之預後分析. Acta Nephrologica, 14(4), 323-323. https://www.airitilibrary.com/Article/Detail?DocID=10131671-200010-14-4-323-323-o
- Chen, C. S., Chung, S. Y., Yu, W. L., & Kao, M. T. (2001). 腹膜透析併發格蘭氏陰性菌腹膜炎之預後分析. Acta Nephrologica, 15(2), 66-70. https://www.airitilibrary.com/Article/Detail?DocID=10131671-200104-15-2-66-70-a
- 吳勝文（2021）。COVID-19 Vaccination Recommendations for Dialysis Patients。腎臟與透析，33(3)，144-147。https://doi.org/10.6340/KD.202109_33(3).0008